Organ care products are medical devices designed to store donated organs for longer periods while still providing the organ with the necessary nutrients. These devices are used to keep organs safe for a set amount of time before transplantation. This technology assists in monitoring organs such as the kidney, liver, to ensure that they are operating at their best. Organ care products contain one or more pump units, thermo units, and trolleys.
Accord Healthcare and TransMedics – Notable Market Players in Organ Care Products Market
Leading companies operating in the market have undertaken various organic growth strategies in the market. The organ care products market is majorly comminated by TransMedics; XVIVO Perfusion AB; Bridge to Life; Paragonix Technologies, Inc; OrganOx Limited; Preservation Solution, Inc.; Accord Healthcare; Dr. Franz Koehler Chemie GmbH; Waters Medical Systems LLC; Organ Recovery Systems, Inc. amongst others. The companies have been implementing various strategies that have helped their growth and, in turn, brought about several breakthroughs and transitions in the industry. The companies have utilized organic strategies such as launches, expansion, and product approvals. Moreover, the market players have also deployed several utilized inorganic strategies, including mergers & acquisitions, partnerships, and collaborations.
Below are the major growth strategies undertaken by the players operating in the global organ care products market:
| Year | News |
| February, 2021 | Bridge to Life, Ltd., and Tevosol, Inc., announced their merger to develop and commercialize groundbreaking new products for the organ transplantation community. The arrangement includes Bridge to Life’s significant financial commitment to manufacture, trial, and launch Tevosol’s portable ex-vivo lung perfusion (EVLP) machine and normothermic organ preservation platform. |
| October, 2021 | Paragonix Technologies has announced the clinical and commercial launch of LIVERguard Donor Liver Preservation System in both the US and Europe, along with the launch of its clinical global registry, GUARDIAN-LIVER (Global Utilization and Registry Database for Improved preservation of donor LIVERs). This system is designed for the consistent and repeatable standardized cold storage of livers, regardless of teams, time, geography, or the unforeseen |
| December, 2021 | OrganOx has announced the USFDA premarket approval of metra system. It is fully automated NMP device for the preservation and transport of donor livers destined for transplantation. The marketing approval includes both livers from donors after brain death (DBD) and livers from donors after circulatory death (DCD). |
| September, 2021 | TransMedics Group, Inc. has announced the USFDA premarket approval for its OCS Liver System for use with organs from donors after brain death (DBD) and after circulatory death (DCD). It is used for the preservation and monitoring of hemodynamics and metabolic function which allows for ex-vivo assessment of liver allografts from DBD and DCD donor livers based on OCS Liver PROTECT Trial. |
| September, 2020 | XVIVO Perfusion acquired the Dutch medtech company Organ Assist and finances the acquisition through a private placement of new shares. |
| March, 2020 | NAPLES trial (Normothermic mAchine Perfusion of the Liver to Enable transplantation in difficult recipientS) with the OrganOx metra were presented for the first time at the British Transplant Society meeting in Belfast, and the presentation won the Medawar Medal for best clinical paper. |
